Global Injectable Drug Delivery Devices Market 2022-2026: Digitalization of Healthcare Sector Driving Growth – ResearchAndMarkets.com

Global Injectable Drug Delivery Devices Market 2022-2026: Digitalization of Healthcare Sector Driving Growth - ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Injectable Drug Delivery Devices Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering.

The injectable drug delivery devices market is poised to grow by $22.29 bn during 2022-2026, progressing at a CAGR of 8.48% during the forecast period. The report on the injectable drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases and growth in the biologics market.

The injectable drug delivery devices market analysis includes the type segment and geographic landscape.

The injectable drug delivery devices market is segmented as below:

By Type

Advanced injectable drug delivery devices

Conventional injectable drug delivery devices

By Geography

North America

Europe

Asia

ROW

This study identifies digitalization in the healthcare system as one of the prime reasons driving the injectable drug delivery devices market growth during the next few years.

The report on injectable drug delivery devices market covers the following areas:

Injectable drug delivery devices market sizing

Injectable drug delivery devices market forecast

Injectable drug delivery devices market industry analysis

Key Topics Covered:

Executive Summary

Market Landscape

Market Sizing

Five Forces Analysis

Market Segmentation by Type

Customer landscape

Geographic Landscape

Drivers, Challenges, and Trends

Vendor Landscape

Vendor Analysis

Appendix

Companies Mentioned

AstraZeneca Plc

Baxter International Inc.

Becton Dickinson and Co.

Eli Lilly and Co.

Gerresheimer AG

Owen Mumford Ltd.

Sanofi SA

SCHOTT AG

Teva Pharmaceutical Industries Ltd.

Viatris Inc.

For more information about this report visit https://www.researchandmarkets.com/r/relxr2

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.